Abstract
A REVIEW ON DIABETES INDUCED MEMORY IMPAIRMENT
Priyanka*, Chitra Gupta and Somya Sah
ABSTRACT
AD is a progressive neurotic degenerative brain disorder that occurs gradually and results in memory loss, unusual behaviour, personality changes. Diabetes is a group of complex metabolic disease characterized by hyperglycemia. The development of cognitive dysfunction in patient with diabetes includes many hypothesis include potential causative role of hyperglycemia, vascular disease, insulin resistance, hypoglycaemia and amyloid deposition. AGE’S are considered significant biomarkers of oxidative stress and markers of carbonyl stress which occur due to an amplified level of sugars and reactive dicarbonyl compounds. Metformin is an oral biguanide, generically available diabetes drug that is the first line treatment for type 2 diabetes. there is confirmation from clinical studies that metformin does cross the BBB and activates AMPK in CNS tissue. In nerve cell lines, contact to metformin sensitizes neurons to insulin and also prevents memory impairment pathology in neurons chronically exposed to a hyperinsulinemic environment.
[Full Text Article] [Download Certificate]WJPLS CITATION 
All | Since 2020 | |
Citation | 590 | 424 |
h-index | 12 | 10 |
i10-index | 17 | 14 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here